Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIVANTAMAB-VMJW: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

64.4%
Female
35.6%
Male

Age Information

The average age of patients reporting adverse events with AMIVANTAMAB-VMJW is 66.0 years.

Geographic Distribution

The majority of adverse event reports for AMIVANTAMAB-VMJW originate from US.

Report Summary & Outcomes

2,005
Total Reports
2,005
As Primary/Secondary Suspect
159
Deaths Reported
362
Hospitalizations
41
Life-Threatening
7
Disabilities

Reporting Timeline

First adverse event report: 202106. Most recent report: 20250923. View full timeline →

More About AMIVANTAMAB-VMJW

AMIVANTAMAB-VMJW Full Profile Reports by Year Drug Interactions